Streetbeat News

Products Services

INCY

Incyte announced positive results from a Phase 2 study of Povorcitinib (INCB54707) for treating prurigo nodularis, meeting its primary endpoint with significant improvement in itch compared to placebo.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 9:36 am

INCY

Incyte announced positive results from a Phase 2 study of Ruxolitinib Cream (Opzelura) in treating Hidradenitis Suppurativa, meeting its primary endpoint with a significant reduction in abscess and inflammatory nodule count versus vehicle control.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 9:34 am

AMGN

Amgen announced new 52-week results from the Phase 3 SPROUT study of Otezla (Apremilast) in children and adolescents aged 6 to 17 years with moderate to severe plaque psoriasis on Saturday.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 9:13 am

ARQT

Arcutis Biotherapeutics released new data from its INTEGUMENT-PED Phase 3 study of Roflumilast Cream for treating children aged 2 to 5 with mild to moderate atopic dermatitis. The results showed significant improvements across multiple efficacy endpoints and at all timepoints.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 9:11 am

LLY

Eli Lilly announced positive results from a study of Lebrikizumab in individuals with skin of color suffering from moderate-to-severe atopic dermatitis, showing significant improvement in skin clearance and itch relief.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 9:08 am

FSM

Fortuna Silver Mines announced the discovery of the new Kingfisher prospect at the Séguéla mine and provided an exploration update at the Diamba Sud gold project. This discovery and update could indicate potential growth and increased resource estimates for the company.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 9:02 am

CXM

GOOG

Sprinklr has announced a local data hosting solution in Saudi Arabia in collaboration with Google Cloud, allowing customers to host data in the region to comply with local regulations. This service is in addition to Sprinklr's existing hosting solutions in the US on Google Cloud.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:32 am

AAPL

Apple Inc. is set to introduce a 'hearing aid mode' for AirPods Pro with the iOS 18 update, building on existing features like Live Listen and Conversation Boost. This aligns with Apple's focus on enhancing accessibility in its devices.

Portfolio Pulse from Ananya Gairola

March 11, 2024 | 8:30 am

IBM

Short-seller Jim Chanos criticized IBM for its rumored job cuts and questioned the company's growth prospects, highlighting AI as both a risk and opportunity for IBM's business model. The Register reported IBM is seeking voluntary redundancies, targeting mainly the Enterprise Operations & Support and Q2C missions, Finance & Operations. IBM's Q4 results showed a 4% revenue growth, and CFO Jim Kavanaugh discussed productivity initiatives and AI-driven efficiencies aiming for $3 billion in cost savings by 2024. IBM's stock closed down 0.30% at $195.95.

Portfolio Pulse from Shanthi Rexaline

March 11, 2024 | 8:12 am

BTCUSD

Bitcoin's recent surge has sparked optimism for the revival of the broader cryptocurrency market, despite a report revealing 72% of crypto projects since 2020 have failed. The introduction of spot Bitcoin ETFs in the U.S. and Bitcoin's price reaching an all-time high have contributed to renewed interest in the crypto space. Analysts predict Bitcoin could hit $100,000 by year-end, with factors like ETF inflows, the upcoming halving, and looser interest rates playing a role. Cathie Wood of ARK Invest forecasts a Bitcoin price of $600,000 by 2030, while hedge fund manager Bill Ackman considers Bitcoin as an inflation hedge.

Portfolio Pulse from Benzinga Neuro

March 11, 2024 | 6:54 am